O	0	1	A
O	2	7	pilot
O	8	18	randomized
O	19	29	controlled
O	30	35	trial
O	36	38	of
B-intervention	39	48	telephone
I-intervention	49	61	intervention
O	62	64	to
O	65	73	increase
O	74	80	Breast
O	81	87	Cancer
O	88	97	Screening
O	98	104	uptake
O	105	107	in
O	108	116	socially
O	117	125	deprived
O	126	131	areas
O	132	134	in
B-location	135	143	Scotland
O	144	145	(
O	145	153	TELBRECS
O	153	154	)
O	154	155	.

O	156	158	To
O	159	168	determine
O	169	176	whether
O	177	178	a
O	179	184	brief
O	185	194	telephone
O	195	202	support
O	203	215	intervention
O	216	221	could
O	222	230	increase
O	231	237	breast
O	238	244	cancer
O	245	254	screening
O	255	261	uptake
O	262	267	among
O	268	273	lower
O	274	279	socio
O	279	280	-
O	280	291	demographic
O	292	297	women
O	298	300	in
O	301	309	Scotland
O	309	310	,
O	311	314	via
O	315	324	eliciting
O	325	328	and
O	329	339	addressing
O	340	348	barriers
O	349	351	to
O	352	361	screening
O	362	372	attendance
O	372	373	.

O	374	376	In
O	377	378	a
O	379	384	pilot
O	385	395	randomized
O	396	406	controlled
O	407	412	trial
O	412	413	,
B-eligibility	414	426	participants
I-eligibility	427	436	receiving
I-eligibility	437	438	a
I-eligibility	439	447	reminder
I-eligibility	448	454	letter
I-eligibility	455	458	for
I-eligibility	459	460	a
I-eligibility	461	467	missed
I-eligibility	468	477	screening
I-eligibility	478	489	appointment
O	490	491	(
O	491	499	February
O	499	500	-
O	500	504	June
O	505	509	2014
O	509	510	)
O	511	515	were
O	516	526	randomized
O	527	529	to
O	530	534	four
O	535	539	arms
O	539	540	:
B-control	541	543	No
I-control	544	553	telephone
I-control	554	558	call
I-control	559	560	(
I-control	560	567	control
I-control	567	568	)
O	568	569	,
O	570	576	Simple
O	577	586	telephone
O	587	595	reminder
O	596	597	(
O	597	600	TEL
O	600	601	)
O	601	602	,
O	603	612	Telephone
O	613	620	support
O	621	622	(
O	622	625	TEL
O	625	626	-
O	626	630	SUPP
O	630	631	)
O	631	632	,
O	633	635	or
O	636	645	Telephone
O	646	653	support
O	654	658	plus
O	659	670	anticipated
O	671	677	regret
O	678	679	(
O	679	682	TEL
O	682	683	-
O	683	687	SUPP
O	687	688	-
O	688	690	AR
O	690	691	)
O	691	692	.

O	693	700	Primary
O	701	709	outcomes
O	710	714	were
B-outcome-Measure	715	721	making
I-outcome-Measure	722	724	an
I-outcome-Measure	725	736	appointment
O	737	740	and
B-outcome-Measure	741	750	attending
I-outcome-Measure	751	757	breast
I-outcome-Measure	758	767	screening
O	767	768	.

O	769	771	Of
B-total-participants	772	775	856
O	776	781	women
O	782	792	randomized
O	793	796	and
O	797	805	analysed
O	806	808	on
O	809	818	intention
O	818	819	-
O	819	821	to
O	821	822	-
O	822	827	treat
O	828	833	basis
O	833	834	,
O	835	843	compared
O	844	848	with
O	849	857	controls
O	857	858	,
O	859	863	more
O	864	869	women
O	870	872	in
O	873	876	the
O	877	886	telephone
O	887	899	intervention
O	900	906	groups
B-outcome	907	911	made
I-outcome	912	914	an
I-outcome	915	926	appointment
O	927	928	(
O	928	935	control
O	935	936	:
B-cv-bin-percent	937	938	8
I-cv-bin-percent	938	939	.
I-cv-bin-percent	939	940	8
I-cv-bin-percent	940	941	%
O	941	942	,
O	943	946	TEL
O	946	947	:
B-iv-bin-percent	948	950	20
I-iv-bin-percent	950	951	.
I-iv-bin-percent	951	952	3
I-iv-bin-percent	952	953	%
O	953	954	,
O	955	958	TEL
O	958	959	-
O	959	963	SUPP
O	963	964	:
B-iv-bin-percent	965	967	14
I-iv-bin-percent	967	968	.
I-iv-bin-percent	968	969	1
I-iv-bin-percent	969	970	%
O	970	971	;
O	972	975	TEL
O	975	976	-
O	976	980	SUPP
O	980	981	-
O	981	983	AR
O	983	984	:
B-iv-bin-percent	985	987	16
I-iv-bin-percent	987	988	.
I-iv-bin-percent	988	989	8
I-iv-bin-percent	989	990	%
O	990	991	,
O	992	993	χ
O	993	994	(
O	994	995	2
O	995	996	)
O	996	997	(
O	997	998	3
O	998	999	)
O	1000	1001	=
O	1002	1004	12
O	1004	1005	.
O	1005	1006	0
O	1006	1007	,
O	1008	1009	p
O	1010	1011	=
O	1012	1013	.
O	1013	1016	007
O	1016	1017	)
O	1018	1021	and
B-outcome	1022	1030	attended
I-outcome	1031	1037	breast
I-outcome	1038	1047	screening
O	1048	1049	(
O	1049	1056	control
O	1056	1057	:
B-cv-bin-percent	1058	1059	6
I-cv-bin-percent	1059	1060	.
I-cv-bin-percent	1060	1061	9
I-cv-bin-percent	1061	1062	%
O	1062	1063	,
O	1064	1067	TEL
O	1067	1068	:
B-iv-bin-percent	1069	1071	16
I-iv-bin-percent	1071	1072	.
I-iv-bin-percent	1072	1073	5
I-iv-bin-percent	1073	1074	%
O	1074	1075	,
O	1076	1079	TEL
O	1079	1080	-
O	1080	1084	SUPP
O	1084	1085	:
B-iv-bin-percent	1086	1088	11
I-iv-bin-percent	1088	1089	.
I-iv-bin-percent	1089	1090	3
I-iv-bin-percent	1090	1091	%
O	1091	1092	;
O	1093	1096	TEL
O	1096	1097	-
O	1097	1101	SUPP
O	1101	1102	-
O	1102	1104	AR
O	1104	1105	:
B-iv-bin-percent	1106	1108	13
I-iv-bin-percent	1108	1109	.
I-iv-bin-percent	1109	1110	1
I-iv-bin-percent	1110	1111	%
O	1111	1112	,
O	1113	1114	χ
O	1114	1115	(
O	1115	1116	2
O	1116	1117	)
O	1117	1118	(
O	1118	1119	3
O	1119	1120	)
O	1121	1122	=
O	1123	1124	9
O	1124	1125	.
O	1125	1126	8
O	1126	1127	,
O	1128	1129	p
O	1130	1131	=
O	1132	1133	.
O	1133	1136	020
O	1136	1137	)
O	1137	1138	.

O	1139	1141	Of
O	1142	1145	559
O	1146	1151	women
O	1152	1162	randomized
O	1163	1165	to
O	1166	1169	the
O	1170	1175	three
O	1176	1185	telephone
O	1186	1192	groups
O	1192	1193	,
O	1194	1197	404
O	1198	1202	were
O	1203	1215	successfully
O	1216	1225	contacted
O	1226	1229	and
B-total-participants	1230	1233	247
O	1234	1246	participated
O	1247	1249	in
O	1250	1253	the
O	1254	1266	intervention
O	1266	1267	.

O	1268	1280	Intervention
O	1281	1293	participants
O	1294	1295	(
O	1295	1297	ie
O	1297	1298	.
O	1299	1302	per
O	1303	1311	protocol
O	1312	1320	analysis
O	1320	1321	)
O	1322	1326	were
O	1327	1331	more
O	1332	1338	likely
O	1339	1341	to
B-outcome	1342	1346	make
O	1347	1348	(
B-iv-bin-percent	1348	1350	17
I-iv-bin-percent	1350	1351	%
O	1352	1358	versus
B-cv-bin-percent	1359	1361	10
I-cv-bin-percent	1361	1362	%
O	1362	1363	,
O	1364	1365	χ
O	1365	1366	(
O	1366	1367	2
O	1367	1368	)
O	1368	1369	(
O	1369	1370	1
O	1370	1371	)
O	1372	1373	=
O	1374	1375	7
O	1375	1376	.
O	1376	1377	0
O	1377	1378	,
O	1379	1380	p
O	1381	1382	=
O	1383	1384	.
O	1384	1387	008
O	1387	1388	)
O	1389	1392	and
B-outcome	1393	1399	attend
O	1400	1401	(
B-iv-bin-percent	1401	1403	13
I-iv-bin-percent	1403	1404	%
O	1405	1411	versus
B-cv-bin-percent	1412	1413	7
I-cv-bin-percent	1413	1414	%
O	1414	1415	,
O	1416	1417	χ
O	1417	1418	(
O	1418	1419	2
O	1419	1420	)
O	1420	1421	(
O	1421	1422	1
O	1422	1423	)
O	1424	1425	=
O	1426	1427	5
O	1427	1428	.
O	1428	1429	5
O	1429	1430	,
O	1431	1432	p
O	1433	1434	=
O	1435	1436	.
O	1436	1439	019
O	1439	1440	)
O	1441	1443	an
B-outcome	1444	1455	appointment
O	1456	1460	than
O	1461	1464	non
O	1464	1465	-
O	1465	1477	participants
O	1477	1478	,
O	1479	1482	but
O	1483	1488	there
O	1489	1493	were
O	1494	1496	no
O	1497	1508	differences
O	1509	1511	in
O	1512	1522	attendance
O	1523	1530	between
O	1531	1534	the
O	1535	1540	three
O	1541	1550	telephone
O	1551	1557	groups
O	1557	1558	.

O	1559	1560	A
O	1561	1567	simple
O	1568	1577	telephone
O	1578	1586	reminder
O	1587	1594	doubled
O	1595	1605	attendance
O	1606	1608	at
O	1609	1615	breast
O	1616	1625	screening
O	1626	1628	in
O	1629	1634	women
O	1635	1639	from
O	1640	1645	lower
O	1646	1651	socio
O	1651	1652	-
O	1652	1663	demographic
O	1664	1669	areas
O	1670	1673	who
O	1674	1677	had
O	1678	1681	not
O	1682	1690	attended
O	1691	1696	their
O	1697	1704	initial
O	1705	1716	appointment
O	1716	1717	,
O	1718	1726	compared
O	1727	1731	with
O	1732	1733	a
O	1734	1742	reminder
O	1743	1749	letter
O	1750	1754	only
O	1755	1756	(
O	1756	1760	odds
O	1761	1766	ratio
O	1767	1768	2
O	1768	1769	.
O	1769	1771	12
O	1771	1772	,
O	1773	1775	95
O	1775	1776	%
O	1777	1779	CI
O	1780	1781	(
O	1781	1782	1
O	1782	1783	.
O	1783	1784	2
O	1784	1785	,
O	1786	1787	3
O	1787	1788	.
O	1788	1789	8
O	1789	1790	)
O	1790	1791	)
O	1791	1792	.

O	1793	1800	However
O	1800	1801	,
O	1802	1812	contacting
O	1813	1818	women
O	1819	1825	proved
O	1826	1837	problematic
O	1838	1841	and
O	1842	1847	there
O	1848	1851	was
O	1852	1854	no
O	1855	1865	additional
O	1866	1872	effect
O	1873	1875	of
O	1876	1885	telephone
O	1886	1893	support
O	1894	1896	or
O	1897	1908	anticipated
O	1909	1915	regret
O	1915	1916	.
